HIM
OFIX icon

Hillsdale Investment Management’s Orthofix Medical OFIX Stock Holding History

Hillsdale Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,200
Closed -$471K – 710
2025
Q2 		$471K Buy
42,200
+12,000
+40% +$149K 0.02% 401
2025
Q1 		$493K Buy
+30,200
New +$530K 0.03% 366
2021
Q4 		– Sell
-103,200
Closed -$3.93M – 600
2021
Q3 		$3.93M Buy
+103,200
New +$4.11M 0.3% 115
2017
Q1 		– Sell
-200
Closed -$7K – 519
2016
Q4 		$7K Hold
200
– – ﹤0.01% 378
2016
Q3 		$9K Buy
+200
New +$8.93K ﹤0.01% 387

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hillsdale Investment Management's OFIX Position: Q3 2025 in Review

Hillsdale Investment Management sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 42,200 shares — an estimated $471K sold.

Hillsdale Investment Management first reported a position in OFIX in Q3 2016 and held it in 5 quarters. The position peaked at $3.93M in Q3 2021. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Hillsdale Investment Management reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 42,200 Orthofix Medical shares in Q3 2025, an estimated $471K.
  • Hillsdale Investment Management first reported a position in Orthofix Medical in Q3 2016 and held it in 5 quarters.
  • Hillsdale Investment Management's Orthofix Medical position peaked at $3.93M in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.